Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CHKA | P35790 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | HRH1 | P35367 | 1/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | HTR6 | P50406 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6504685 | 0.97 | CA2 (0.36) | CA2CHKAKDM4EHRH1USP2 | |
| SCHEMBL3531750 | 0.97 | CA2 (0.36) | CA2CHKAKDM4EHRH1USP2 | |
| SCHEMBL1513130 | 0.90 | ALDH1A1 (0.43) | CA2CHKAKDM4EHRH1USP2 | |
| SCHEMBL1256068 | 0.88 | ALDH1A1 (0.37) | SMN1; SMN2 | |
| SCHEMBL5549254 | 0.88 | HIF1A (0.31) | CA2 | |
| SCHEMBL4243756 | 0.88 | — | — | |
| SCHEMBL232289 | 0.87 | — | — | |
| SCHEMBL29883467 | 0.85 | ALDH1A1 (0.39) | SMN1; SMN2 | |
| SCHEMBL1258379 | 0.84 | CA2 (0.42) | CA2CHKAKDM4EHRH1USP2 | |
| SCHEMBL336574 | 0.81 | CA2 (0.46) | CA2CHKAKDM4EHRH1USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 120 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115894499-A | Novel natural sulfur-containing alkaloid and preparation method and application thereof | 云南民族大学 | 2023-04-04 | — | — | CN | claimed |
| EP-2914578-A1 | SALTS WITH TRIHYDROPERFLUOROALKOXYBUTANE SULFONATE OR TRIHYDROPERFLUOROALKOXYPROPANE SULFONATE ANION | Merck Patent GmbH (DE) | 2015-09-09 | — | — | EP | claimed |
| EP-2731954-A1 | COMPOUNDS CONTAINING ALKYL-ALKOXY-CYANO-BORATE ANIONS | Merck Patent GmbH (DE) | 2014-05-21 | — | — | EP | claimed |
| EP-2731955-A1 | COMPOUNDS CONTAINING ALKYL-CYANO-BORATE OR ALKYL-CYANO-FLUOROBORATE ANIONS | Merck Patent GmbH (DE) | 2014-05-21 | — | — | EP | claimed |
| WO-2014067603-A1 | SALTS WITH TRIHYDROPERFLUOROALKOXYBUTANE SULFONATE OR TRIHYDROPERFLUOROALKOXYPROPANE SULFONATE ANION | MERCK PATENT GMBH (DE) | 2014-05-08 | — | — | WO | claimed |
| EP-2621934-A1 | ELECTROLYTE FORMULATIONS CONTAINING CYANO-ALKOXY-BORATE ANIONS | Merck Patent GmbH (DE) | 2013-08-07 | — | — | EP | claimed |
| EP-2621939-A1 | FUNCTIONALIZED FLUOROALKYL FLUOROPHOSPHATE SALTS | Merck Patent GmbH (DE) | 2013-08-07 | — | — | EP | claimed |
| WO-2013010640-A1 | COMPOUNDS CONTAINING ALKYL-ALKOXY-CYANO-BORATE ANIONS | MERCK PATENT GMBH (DE) | 2013-01-24 | — | — | WO | claimed |
| WO-2013010641-A1 | COMPOUNDS CONTAINING ALKYL-CYANO-BORATE OR ALKYL-CYANO-FLUOROBORATE ANIONS | MERCK PATENT GMBH (DE) | 2013-01-24 | — | — | WO | claimed |
| WO-2012163490-A1 | ELECTROLYTE FORMULATIONS | MERCK PATENT GMBH (DE) | 2012-12-06 | — | — | WO | claimed |
| EP-1902035-A1 | METHOD FOR THE PRODUCTION OF ONIUM ALKYL SULFITES | Merck Patent GmbH (DE) | 2008-03-26 | — | — | EP | claimed |
| EP-1902004-A2 | ONIUM-ALKYLSULFONATE PRODUCTION METHOD | Merck Patent GmbH (DE) | 2008-03-26 | — | — | EP | claimed |
| US-20070249691-A1 | Mercaptoimidazoles as Ccr2 Receptor Antagonists | JANSSEN PHARMACEUTICA N.V. (BE) | 2007-10-25 | — | — | US | claimed |
| EP-1824827-A1 | METHOD FOR PRODUCING ONIUM SALTS COMPRISING ALKYL ANIONS OR ARYL SULFONATE ANIONS OR ALKYL ANIONS OR ARYL CARBOXYLATE ANIONS HAVING A LOW HALIDE CONTENT | Merck Patent GmbH (DE) | 2007-08-29 | — | — | EP | claimed |
| WO-2007067444-A1 | BICYCLIC COMPOUNDS WITH KINASE INHIBITORY ACTIVITY | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2007-06-14 | — | — | WO | claimed |
| EP-1768962-A1 | METHOD FOR PRODUCING ONIUM SALTS WITH A LOW CHLORIDE CONTENT | MERCK PATENT GmbH (DE) | 2007-04-04 | — | — | EP | claimed |
| WO-2007006388-A1 | METHOD FOR THE PRODUCTION OF ONIUM ALKYL SULFITES | MERCK PATENT GMBH (DE) | 2007-01-18 | — | — | WO | claimed |
| WO-2007006387-A2 | ONIUM-ALKYLSULFONATE PRODUCTION METHOD | MERCK PATENT GMBH (DE) | 2007-01-18 | — | — | WO | claimed |
| WO-2006063656-A1 | METHOD FOR PRODUCING ONIUM SALTS COMPRISING ALKYL ANIONS OR ARYL SULFONATE ANIONS OR ALKYL ANIONS OR ARYL CARBOXYLATE ANIONS HAVING A LOW HALIDE CONTENT | MERCK PATENT GMBH (DE) | 2006-06-22 | — | — | WO | claimed |
| WO-2006007912-A1 | METHOD FOR PRODUCING ONIUM SALTS WITH A LOW CHLORIDE CONTENT | MERCK PATENT GMBH (DE) | 2006-01-26 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070249691-A1 | Mercaptoimidazoles as Ccr2 Receptor Antagonists | CCR2, CCR1, CCR5 | CA2 3069/4885CHKA 945/4885KDM4E 3895/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.